Advances in Pharmacovigilance for Herbal Medicines
Date
12th - 14th April 2023
Venue
Royal Botanic Gardens, Kew, London, United Kingdom
- Conference Overview
- Key Speakers
- Conference Programme
- Tutorial Programme
- Aims of the Conference
- Who Should Attend
- Key Topics
- Registration & Fees
- Book Now
Conference Overview
The use of herbal and traditional medicines for health and well-being, as well as for prevention and treatment of disease, remains a popular choice globally. While herbal and traditional medicines may bring health benefits, as with other medicinal products, there are also associated risks, including a lack of clinical pharmacokinetic and pharmacodynamic data to determine dosages, dose-response relationships and other parameters, as well as poor-quality products. Developments in regulation for herbal and traditional medicines have strengthened pharmacovigilance for these products, but there are challenges in identifying, assessing, monitoring and managing safety concerns.
Key Speakers
- Dr Jeff Aronson, Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- Erika Svedlund, Department of Herbal Medicinal Products, Swedish Medical Products Agency and Vice-Chair, Committee on Herbal Medicinal Products, European Medicines Agency
- Mark Blumenthal / Stefan Gafner, American Botanical Council
- Professor Jo Barnes, Associate Professor in Herbal Medicines, School of Pharmacy, University of Auckland, New Zealand
- Professor Ian CK Wong, Lo Shiu Kwan Kan Po Ling Professor in Pharmacy, Head of Department of Pharmacology and Pharmacy, The University of Hong Kong
- Dr Bob Allkin, The Royal Botanic Gardens, Kew, London, UK
- Professor Souad Skalli, Associate Professor, Faculty of Science, University Mohammed V in Rabat, Rabat, Morocco
- Professor Rich Boyce, Associate Professor of Biomedical Informatics and Clinical and Translational Science, Clinical and Translational Science Institute, and Associate Director, Biomedical Informatics Training Program, University of Pittsburgh, USA
- Amy Roe, Director Principal Toxicologist, Personal Health Care, Procter & Gamble, USA
- Daniele Sartori, Pharmacovigilance Scientist, Uppsala Monitoring Centre, Uppsala, Sweden / PhD Student, Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- Florence van Hunsel, Head Signal Detection, Netherlands Pharmacovigilance Centre (LAREB)
- Kendal Harrison, Interim Head of Vigilance Development, Medicines and Healthcare Products Regulatory Agency (MHRA)
- Phil Rasmussen, Founding Director, Natural Health Products New Zealand
- Olaf Kelber, Distinguished Science Fellow, R&D Phytomedicines, Bayer Phytomedicines Supply and Development Center
- Kristina Patmore, Medicinal Plant Names Service, Royal Botanic Gardens Kew, UK
- Eva Svärd, Terminology Specialist, WHODrug Content Management and Support, Uppsala Monitoring Centre, Sweden
- Dr Debabrata Roy, Head of Epidemiology and Research, Drug Safety Research Unit, UK
- Samantha Lane, Head of Research for the Institute of Pharmacovigilance Sciences and Senior Research Fellow, Drug Safety Research Unit, UK
Conference Programme
Tutorial Programme
Aims of the Conference
This conference aims to provide a comprehensive and critical update on advances in pharmacovigilance activities for herbal and traditional medicines at the national and global levels. The conference will explore challenges in pharmacovigilance for herbal and traditional medicines, developments and new approaches in safety monitoring for these products, various stakeholder perspectives, and future directions.
Who Should Attend
The conference is aimed at individuals working in/as:
- Medicines regulatory authorities and pharmacovigilance centres
- Pharmaceutical industry settings, including the herbal/phytomedicines/complementary medicines industry, particularly those working in pharmacovigilance, medical information, regulatory affairs, product development and marketing
- Academia, particularly in pharmacovigilance/pharmacoepidemiology, pharmacognosy, phytotherapy/herbal medicines, undergraduate and postgraduate health professional programmes
- Pharmacists, doctors, nurses and other health professionals
- Herbal/traditional medicine practitioners and other ‘natural health’/complementary medicine practitioners
- Herbal/traditional medicine practitioners and other ‘natural health’/complementary organisations
- Representatives from non-governmental organisations, such as patient- and health-oriented charities
Key Topics
- Methodological developments and new approaches in pharmacovigilance for herbal medicines
- Patients’ perspectives in pharmacovigilance for herbal medicines
- Towards ‘big data’ for herbal and traditional medicines
- Challenges in coding and classification for herbal and traditional medicines
- Quality of herbal and traditional medicines and implications for safety and pharmacovigilance
- Industry, practitioner and regulatory perspectives in pharmacovigilance for herbal and traditional medicines
Registration & Fees
You can book the conference on its own or with one or both pre-conference tutorials.
Pre-conference tutorial A: Herbal Medicines (morning)
Pre-conference tutorial B: Pharmacovigilance and Pharmacoepidemiology (afternoon)
VAT not applicable for bookings made outside of the UK.
